Inhibitory actions of ZENECA ZD7288 on whole‐cell hyperpolarization activated inward current (If) in guinea‐pig dissociated sinoatrial node cells
Open Access
- 1 September 1993
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 110 (1) , 343-349
- https://doi.org/10.1111/j.1476-5381.1993.tb13815.x
Abstract
1 ZENECA ZD7288 (4-(N-ethyl-N-phenylamino)-1,2-dimethyl-6-(methylamino) pyrimidinium chloride) is a sinoatrial node (SAN) modulating agent which produces a selective slowing of the heart rate. Its effects have been studied in single, freshly dissociated guinea-pig SAN cells, by standard patch clamp procedures. 2 Whole-cell inward currents were evoked by hyperpolarizing voltage clamp steps from a holding potential of −40 mV. ZD7288 inhibited the hyperpolarization activated cationic current (If) in a concentration-dependent manner. The ‘selective bradycardic agents' alinidine and UL-FS 49 (zatebradine) both also inhibited If. 3 The activation of If was investigated by measuring tail current amplitudes at +20 mV after hyperpolarizing steps to different potentials to activate the current. The reduction in If resulted from both a shift in the If current activation curve in the negative direction on the voltage axis, and also a reduction in the activation curve amplitude. 4 ZD7288 did not affect the ion selectivity of the If channel, since the tail current reversal potential was unchanged in the presence of the drug. 5 With ZD7288 the inhibition of If was not use-dependent, whereas UL-FS 49 displayed use-dependence in the block of the If current. 6 Whereas ZD7288 had no significant effect on the delayed rectifier current (Ik) in these cells, both alinidine and UL-FS 49 significantly reduced Ik at the same concentrations which reduced If. 7 The data show that ZD7288 reduces If by affecting the activation characteristics of the If current; this inhibition may account for this agent's selective bradycardic properties.Keywords
This publication has 30 references indexed in Scilit:
- ICI D7288, a Novel Sinoatrial Node ModulatorJournal of Cardiovascular Pharmacology, 1993
- Calmodulin antagonists inhibit endothelium‐dependent hyperpolarization in the canine coronary arteryBritish Journal of Pharmacology, 1992
- Cyclopiazonic acid, an inhibitor of the sarcoplasmic reticulum Ca2+‐pump, reduces Ca2+‐dependent K+ currents in guinea‐pig smooth muscle cellsBritish Journal of Pharmacology, 1992
- Use- and frequency-dependent blockade by UL-FS 49 of the if pacemaker current in sheep cardiac Purkinje fibresEuropean Journal of Pharmacology, 1990
- Mechanisms of impulse generation in isolated cells from the rabbit sinoatrial nodeJournal of Molecular and Cellular Cardiology, 1989
- The pacemaker current in the sinus nodeEuropean Heart Journal, 1987
- Mechanism of beneficial effect of beta-adrenergic blockade on exercise-induced myocardial ischemia in conscious dogs.Circulation Research, 1987
- Elimination of exercise-induced regional myocardial dysfunction by a bradycardiac agent in dogs with chronic coronary stenosis.Circulation, 1987
- Electrophysiological study of alinidine in voltage clamped rabbit sino-atrial node cellsEuropean Journal of Pharmacology, 1986
- Cardiovascular characterisation of UL-FS 49,1,3,4,5-tetrahydro-7,8-dimethoxy-3-[3-[[2-(3,4-dimethoxyphenyl)ethyl]methylimino]propyl]-2H-3-benzazepin- 2-on hydrochloride, a new “specific bradycardic agent”European Journal of Pharmacology, 1984